TrialPath

Find a study

Browse recruiting studies near you — free to check, always your choice.

Match me to a study

411 studies

Recruiting now, in plain language. Every study is watched over by an independent ethics board.

ListMap
Weight & metabolicPeptide & GLP-1Mental healthLungs & breathingHeart & circulationKidneyBrain & memoryBlood disordersImmune & autoimmuneSkin

135 studies on the map

Exercise Neuroprotection in Parkinson's Disease — Gait and Balance Laboratory, 217 Bigelow Health Sciences Building, UNLV, Las VegasMolecular Signatures of Cutaneous Dupilumab Response — University of California, San Francisco, San FranciscoA Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease — Research Site, BirminghamA Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring — Pfizer, New YorkParkinson's Foundation PD GENEration Genetic Registry — University of Alabama Birmingham, BirminghamDaily Amino Acid Supplementation for People With Parkinson's Disease — University of Connecticut, StorrsGenetic Variation in IgG in Alpha 1 Antitrypsin Deficiency — University of Alabama at Birmingham, BirminghamMindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF — VA Boston, BostonTURN-IT FOG: Improving Turning and Freezing of Gait in People With PD — Arizona State University, TempePhase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments — Domino's Farms, Ann ArborEffects of RAS on Gait in PD Patients With DBS — Johns Hopkins School of Medicine, BaltimoreVirtual tES Device Treatment for Parkinson's Disease Motor Symptoms — U LLC Headquarters, ClevelandSleep-specific DBS Therapy in Parkinson's Disease — University Of Minnesota, MinneapolisEfficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype — University of Alabama at Birmingham- Site Number : 8400003, BirminghamCortical Correlates of Gait in Parkinson's Disease: Impact of Medication and Cueing — Oregon Health and Science University, PortlandEffects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease — The Regenesis Project, Santa MonicaTargeted Motor Learning to Improve Gait for Individuals With Parkinson Disease — University of North Carolina at Chapel Hill, Chapel HillA Study to Learn About Study Medicine Called PF-08049820 in People With Eczema — Northridge Clinical Trials, NorthridgeColonic Tissue Biopsy Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis or REM Sleep Behavior Disorder — Digestive Disease Associates, BranfordClinical Trial Evaluating the Efficacy and Safety of AGB101 for Treatment of Parkinson's Disease Related Psychosis — Johns Hopkins, BaltimoreChanges in Movement, Fitness, and Quality of Life in People With Parkinson's Disease After Different Exercise Programs — University of Texas at El Paso Doctor of Physical Therapy and Movement Sciences Building, El PasoA Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease — Banner Sun Health Research Institute, Sun CityA Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD) — UAB Lung Health Center, BirminghamEffects Of Osteopathic Manipulative Medicine(OMM) On Lower Extremity Muscle Characteristics In Parkinson's Disease(PD) Patients — NYIT College of Osteopathic Medicine, Old WestburyA Study to Evaluate Feasibility, Safety, and Clinical Responses of Implanting Autologous Peripheral Nerve Tissue Into the Brain for Non-motor or Motor Symptoms in Patients With Parkinson's Disease Undergoing DBS Surgery — University of Kentucky, LexingtonPhenotyping Resting and Exertional Right Ventricular Dysfunction Among Patients With Chronic Obstructive Pulmonary Disease — University of Colorado Anschutz Medical Campus, AuroraModerate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease — Atlanta VA Medical and Rehab Center, Decatur, GA, DecaturApathy in Parkinson Disease TMS Study — UNC-Chapel Hill, Cassidy Lab, Chapel HillCharacterizing the Pathophysiological Role of the Pallido-thalamocortical Motor Pathway in Parkinson's Disease. — University of Minnesota, MinneapolisA Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006) — Research Site, FoleyEvaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis — National Institutes of Health Clinical Center, BethesdaSegwayPD: The Effect of Sensory-augmented Postural Training Using Segway on Motor and Cognitive Function in Individuals With Parkinson's Disease — University of Texas Southwestern Medical Center, DallasA Study of Buntanetap in Participants With PD — University of Alabama at Birmingham, BirminghamMetabolic Profiling of Immune Responses in Immune-mediated Diseases — National Institutes of Health Clinical Center, BethesdaCardamom and Topical Roseomonas in Atopic Dermatitis — National Institutes of Health Clinical Center, BethesdaPET Imaging Evaluation of [11C]SY08 — MGH, CharlestownRegistry for Systemic Eczema Treatments — Johns Hopkins University, BaltimoreA US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications — Banner Alzheimer's Institute (BAI)-Phoenix, PhoenixImpact of a Biophoton Therapy on Patients With Brain Disorders — Tesla MedBed Center, 139 Pittsburgh Road, Butler, PA 16001, ButlerA Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up — National Institutes of Health Clinical Center, BethesdaFeasibility and Safety of a Portable Exoskeleton to Improve Mobility in Parkinson's Disease — Richmond VA Medical Center, Richmond, VA, RichmondThe Effects of Positive Airway Pressure on the Mucolytic Effects of NAC (TEAM) — UCSF Airway Clinical Research Center, San FranciscoEvaluation of [¹⁸F]MODAG-009 PET Imaging in Synucleinopathies — Institute for Neurodegenerative Disorders and XingImaging, LLC, New HavenEffectiveness of the WearME System for COPD Severity and Respiratory Function — Johns Hopkins, BaltimoreStriatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation — University of Michigan, Ann ArborA Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease — Banner Sun Health Research Institute, Sun CityA Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease — Barrow Neurological Institute, PhoenixDepemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2) — GSK Investigational Site, SheffieldTo Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment — DM Clinical Research - Phoenix, PhoenixSocial & QoL Behaviors in Parkinson's Disease — The George Washington University, Washington D.C.Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults — Galderma Investigational Site - 8893, BirminghamSimplified, Scalable, 24-hour Adaptive DBS in Parkinson's Disease — University of California San Francisco, San FranciscoGenetics and Aerobic Exercise to Slow Parkinson's Disease Trial — The Cleveland Clinic, ClevelandA Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis — Investigational Site, Fountain ValleySpeech Learning and Speech Production in Parkinson's Disease — State University of New York at Buffalo, BuffaloSpinal Cord Stimulation for Parkinson's Disease Rehabilitation — Frazier Rehab Institute, LouisvilleA Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema — Cahaba Dermatology & Skin Health Center, LLC, BirminghamA Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD) — First OC Dermatology, IrvineThe ROAM Research Study Therapy (LTOT) Version — University of Virginia, CharlottesvilleEmphysema Research Registry and Biosample Repository — University of Pittsburgh Emphysema/COPD Research Center, PittsburghOptimizing Deep Brain Stimulation to Improve Visuomotor Function in Parkinson's Disease — Louis Stokes VA Medical Center, Cleveland, OH, ClevelandDupilumab De-escalation in Pediatric Atopic Dermatitis — Johns Hopkins Univerisity, BaltimoreSafety and Tolerability of Patterned Stimulation for DBS in the Home Setting — University of Florida, GainesvilleEndurance Exercise & Virtual Reality for Optimizing Cortical Excitability and Neuroplasticity in PD — UT Health San Antonio- Dept. of Physical Therapy, San AntonioStereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor — Vanderbilt University Medical Center, NashvilleRegistry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry — Neurology and Pain Specialty, Aliso ViejoPhoton-counting CT in Chest Imaging — Duke University Hospital, DurhamModifiable Variables in Parkinsonism (MVP) — Bastyr University, KenmoreNatural History and Genetics of Food Allergy and Related Conditions — National Institutes of Health Clinical Center, BethesdaA Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis — Mountain West Derm - Blackhart PLLC dba Skin Cancer and Dermatology Institute, PhoenixCOPD Patient-Powered Research Network — COPD Foundation, Washington D.C.Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis — Oregon Health & Science University, PortlandStudy to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population — Syneos Health (remote site), MorrisvilleValidation of Chronic Obstructive Pulmonary Disease (COPD) Algorithm — Wake Forest University Health Sciences, Winston-SalemEffects of Vagal Nerve Stimulation on Leg Muscle Activity and Posture in Parkinson's Disease — Movement Disorders Laboratory, MinneapolisHome Hospital for Suddenly Ill Adults — Brigham and Women's Hospital, BostonOpen-label Study to Evaluate Brain α-Synuclein Deposition Using PET and [18F]MK-0947 in Parkinson's Disease — Invicro (dba Perceptive), New HavenAdaptive DBS to Offset STN Dysregulation During Exercise in PD — University of Colorado, AuroraGlobus Pallidus Stimulation to Treat Insomnia — Mayo Clinic in Florida, JacksonvilleImpact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome) — John D. Dingell VA Medical Center, Detroit, MI, DetroitStudy in Parkinson Disease of Exercise — University of Alabama at Birmingham, BirminghamStimulus-Evoked Directional Field Potentials to Guide Subthalamic and Pallidal DBS for PD — University of Alabama at Birmingham, BirminghamA Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis — Inmagene Site 1, LancasterStudy to Evaluate Soquelitinib in Participants With Moderate to Severe AD — Corvus Clinical Trials, South San FranciscoFlourish: Exploring the Early Infant Gut Microbiome — Seeding Labs INC, AustinPercept Transitions in FOG and PD — University of Minnesota, Movement Disorders Lab, MinneapolisPh 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234 — Clinical Site 101, Fair LawnRemote Haptic Rehabilitation for Parkinson's Disease — Virginia Tech, BlacksburgMulti-Center Clean Air Randomized Controlled Trial in COPD — University of Alabama, Lung Health Center, BirminghamFunctional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention — Boise VA Medical Center, BoiseOnline Motor Control in People With Parkinson's Disease — University of Delaware, NewarkImaging Depression in Parkinson's Disease — Yale University, New HavenZesty Exercise System for Therapeutic Engagement — Emory University, 57 Executive Park S NE, Ste 200, AtlantaA Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease — Collaborative Neuroscience Network - CNS, Los AlamitosBreathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH — Rocky Mountain Regional VA Medical Center, Aurora, CO, AuroraKetamine for Veterans With Parkinson's Disease — San Francisco VA Medical Center, San Francisco, CA, San FranciscoBronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3 — University of Alabama at Birmingham, BirminghamTreatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome — Icahn School of Medicine at Mount Sinai, New YorkA Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis — Hamilton Research, LLC, AlpharettaSAD Study in Patients With Parkinson's Disease and Motor Fluctuations — Rocky Mountain Clinical Research, EnglewoodUniversity of Michigan COPD Identification Through Lung Cancer Screening Cohort Study - MAP2 — University of Michigan, Ann ArborNYSCF Scientific Discovery Biobank — New York Stem Cell Foundation Research Institute, New YorkVirtual Cycling Environments for Persons With Parkinson Disease — School of Health Professions, NewarkEfficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype — Chandler Clinical Research Trials- Site Number : 8400025, ChandlerEarly Longitudinal Imaging in the Parkinson's Progressive Marker Initiative (PPMI) Using (18F)AV-133 (PPMI AV-133 Prodromal Imaging) — Institute for Neurodegenerative Disorders, New HavenSodium in the Skin and Atopic Dermatitis — San Francisco VA Medical Center, San FranciscoLebrikizumab in Moderate-to-severe Atopic Dermatitis — Physioseq USA - CA, FolsomAdapting rHIRE and Sleep Monitoring in Parkinson's Disease — University of Colorado Anschutz Medical Campus, AuroraCombined Zephyr Valve System With Inter-lobar Fissure Completion for Lung Volume Reduction in Emphysema — Beth Israel Deaconess Medical Center, BostonEvaluation of a Decision Aid for Deep Brain Stimulation Surgery for Parkinson's Disease — University of Colorado Anschutz, AuroraPsilocybin Therapy for Depression in Parkinson's Disease — University of California, San Francisco, San FranciscoAdaptive Neurostimulation to Restore Sleep in Parkinson's Disease (Aim 2) — University of Nebraska Medical Center, OmaharTMS Over the Dorsolateral Prefrontal Cortex for the Treatment of Impulse Control Disorders in Parkinson's Disease — West Virginia University Hospitals, MorgantownCorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry — CorEvitas, LLC, WalthamA Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis — Applied Research Center Of Arkansas /ID# 268547, Little RockIdentification of Prodromal Neurodegeneration in Serotonergic-Induced REM Sleep Behavior Disorder — University of Minnesota, MinneapolisCortical Electrophysiology of Response Inhibition in Parkinson's Disease — Emory University Hospital, AtlantaLow Voltage Electrical Stimulation for Depression in Parkinson's Patients — University of South Alabama, MobileReal-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States: — Parkinson's Disease and Movement Disorders Center - Orange County (South), Aliso ViejoTemple Health Chest Initiative (THCI 2.0) — Temple University Of the Commonwealth System of Higher Education, PhiladelphiaTopical Treatment for Atopic Dermatitis — Wake Forest University Health Sciences, Winston-SalemRademikibart Add-on Treatment of an Acute COPD Exacerbation (Seabreeze STAT COPD) — University of Alabama at Birmingham Lung Health Center, BirminghamTitrated Ambulatory Oxygen in Fibrotic ILD and COPD With Isolated Exertional Hypoxemia — State University of New York at Buffalo Jacobs School of Medicine and Biomedical Sciences, BuffaloA Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP) — Equity Medical Bowling Green, Bowling GreenDepemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1) — GSK Investigational Site, Loxahatchee GrovesmyAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home — UAB School of Medicine/Lung Health Center, BirminghamInvestigating Subcortical Contributions to Speech Sequencing in Deep Brain Stimulator Recipients — Boston University, BostonPiMZ Longitudinal Cohort (PiMZ Logic) — University of Alabama at Birmingham, BirminghamThe Impact of Botox on Neuroimmune Interactions in Atopic Dermatitis — University of Pittsburgh Medical Center, PittsburghVestibular and Cortical Contributions to Transitions in Freezing of Gait in Parkinson's Disease — University of Minnesota, Movement Disorders Lab, MinneapolisEthnic Differences in Mechanisms of Action of Dupilumab — University of Michigan, Ann ArborBlood Flow Restriction for Optimizing Balance in Parkinson's Disease — University of Texas Health Science Center at San Antonio, San AntonioPRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD. — University of Colorado, DenverAcoustic Waveform Respiratory Evaluation — Indiana University, IndianapolisLeveraging Lung Cancer Screening to Optimize Screening Outcomes and COPD Management: COPD in LCS Registry — Thomas Jefferson University, Philadelphia

Showing the 150 nearest — narrow your filters for fewer, closer studies.